In the past week, TECX stock has gone down by -3.01%, with a monthly decline of -38.38% and a quarterly plunge of -52.72%. The volatility ratio for the week is 11.60%, and the volatility levels for the last 30 days are 8.26% for Tectonic Therapeutic Inc The simple moving average for the last 20 days is -12.89% for TECX stock, with a simple moving average of -27.06% for the last 200 days.
Is It Worth Investing in Tectonic Therapeutic Inc (NASDAQ: TECX) Right Now?
The 36-month beta value for TECX is also noteworthy at 1.27. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for TECX is 10.61M, and at present, short sellers hold a 8.90% of that float. The average trading volume of TECX on March 19, 2025 was 327.75K shares.
TECX) stock’s latest price update
Tectonic Therapeutic Inc (NASDAQ: TECX)’s stock price has plunge by -8.51relation to previous closing price of 23.96. Nevertheless, the company has seen a -3.01% plunge in its stock price over the last five trading sessions. seekingalpha.com reported 2025-02-05 that Positive interim results released from phase 1b study, using TX45 for the treatment of patients with pulmonary hypertension heart failure with preserved ejection fraction. Data from phase 1b study using TX45 for the treatment of patients with pulmonary hypertension heart failure with reduced ejection fraction, expected in 2nd half of 2025. In the 7 major markets, the heart failure market is expected to grow to $33.7 billion in 2032.
Analysts’ Opinion of TECX
Many brokerage firms have already submitted their reports for TECX stocks, with Raymond James repeating the rating for TECX by listing it as a “Outperform.” The predicted price for TECX in the upcoming period, according to Raymond James is $65 based on the research report published on November 20, 2024 of the previous year 2024.
Wells Fargo, on the other hand, stated in their research note that they expect to see TECX reach a price target of $55. The rating they have provided for TECX stocks is “Overweight” according to the report published on August 22nd, 2024.
TECX Trading at -36.56% from the 50-Day Moving Average
After a stumble in the market that brought TECX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -64.11% of loss for the given period.
Volatility was left at 8.26%, however, over the last 30 days, the volatility rate increased by 11.60%, as shares sank -30.59% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -52.02% lower at present.
During the last 5 trading sessions, TECX fell by -3.01%, which changed the moving average for the period of 200-days by +24.26% in comparison to the 20-day moving average, which settled at $25.16. In addition, Tectonic Therapeutic Inc saw -52.52% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TECX starting from SPRINGER TIMOTHY A, who purchase 660,000 shares at the price of $50.00 back on Feb 05 ’25. After this action, SPRINGER TIMOTHY A now owns 970,223 shares of Tectonic Therapeutic Inc, valued at $33,000,000 using the latest closing price.
SPRINGER TIMOTHY A, the Director of Tectonic Therapeutic Inc, purchase 129,294 shares at $54.14 during a trade that took place back on Feb 05 ’25, which means that SPRINGER TIMOTHY A is holding 4,226,058 shares at $6,999,977 based on the most recent closing price.
Stock Fundamentals for TECX
The total capital return value is set at -0.32. Equity return is now at value -36.32, with -32.93 for asset returns.
Based on Tectonic Therapeutic Inc (TECX), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -11.8. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -911.34.
Currently, EBITDA for the company is -43.17 million with net debt to EBITDA at 3.43. The liquidity ratio also appears to be rather interesting for investors as it stands at 9.39.
Conclusion
In summary, Tectonic Therapeutic Inc (TECX) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
